These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20873154)

  • 1. [Morphological changes in the ocular structures in the simulation of proliferative vitreoretinopathy and in the presence of an extraocular focus of chronic infection].
    Boĭko EV; Shishkin MM; Riabous EA; Lepneva SV
    Vestn Oftalmol; 2010; 126(4):25-30. PubMed ID: 20873154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy.
    Shinohara K; Tanaka M; Sakuma T; Kobayashi Y
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):299-305. PubMed ID: 12875458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
    Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.
    Berger AS; Cheng CK; Pearson PA; Ashton P; Crooks PA; Cynkowski T; Cynkowska G; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2318-25. PubMed ID: 8843916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new model of proliferative vitreoretinopathy.
    Frenzel EM; Neely KA; Walsh AW; Cameron JD; Gregerson DS
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2157-64. PubMed ID: 9761295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental model for proliferative vitreoretinopathy by intravitreal dispase: limited by zonulolysis and cataract.
    Kralinger MT; Kieselbach GF; Voigt M; Hayden B; Hernandez E; Fernandez V; Parel JM
    Ophthalmologica; 2006; 220(4):211-6. PubMed ID: 16785750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy.
    Bali E; Willermain F; Caspers-Velu L; Dubois C; Dehou MF; Velu T; Libert J; Bruyns C
    Int J Mol Med; 2003 Sep; 12(3):305-10. PubMed ID: 12883645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense oligonucleotide targeting c-fos mRNA limits retinal pigment epithelial cell proliferation: a key step in the progression of proliferative vitreoretinopathy.
    Zhang L; Li X; Zhao M; He P; Yu W; Dong J; Liu G; Li C; Shi X
    Exp Eye Res; 2006 Dec; 83(6):1405-11. PubMed ID: 16973160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different fixative solutions on eyes with experimental proliferative vitreoretinopathy.
    Nassar K; Lüke J; Lüke M; Kamal M; Soliman MM; Grisanti S; Grisanti S
    Int J Exp Pathol; 2015 Apr; 96(2):103-10. PubMed ID: 25670226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.
    Oshima Y; Sakamoto T; Hisatomi T; Tsutsumi C; Ueno H; Ishibashi T
    Gene Ther; 2002 Sep; 9(18):1214-20. PubMed ID: 12215888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy.
    Ozerdem U; Mach-Hofacre B; Cheng L; Chaidhawangul S; Keefe K; McDermott CD; Bergeron-Lynn G; Appelt K; Freeman WR
    Curr Eye Res; 2000 Jun; 20(6):447-53. PubMed ID: 10980656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of integrin-linked kinase with a small interfering RNA suppresses progression of experimental proliferative vitreoretinopathy.
    Guo L; Yu W; Li X; Zhao G; Liang J; He P; Wang K; Zhou P; Jiang Y; Zhao M
    Exp Eye Res; 2008 Dec; 87(6):551-60. PubMed ID: 18926819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of extracellular ATP-induced Müller cell responses in a dispase model of proliferative vitreoretinopathy.
    Francke M; Weick M; Pannicke T; Uckermann O; Grosche J; Goczalik I; Milenkovic I; Uhlmann S; Faude F; Wiedemann P; Reichenbach A; Bringmann A
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):870-81. PubMed ID: 11867610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The specific features of a structural lesion in the ocular posterior segment in experimental chlamydial infection].
    Boĭko EV; Chepur SV; Pozniak AL; Nuralova IV; Suetov AA; Mal'tsev DS; Ageev VS; Shestaev AIu
    Vestn Oftalmol; 2010; 126(1):27-32. PubMed ID: 20645572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of hypericin on traumatic proliferative vitreoretinopathy in rabbits].
    Gao Q; Hui Y; Wang Y
    Yan Ke Xue Bao; 2002 Dec; 18(4):240-5. PubMed ID: 15515769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Structural changes of the retina and corpus vitreum in the model of proliferative vitreoretinopathy in alloxan diabetes].
    Logvinov SV; Krivosheina OI; Zapuskalov IV; Varakuta EIu; Potapov AV
    Morfologiia; 2005; 127(3):34-7. PubMed ID: 16381309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of Chlamydia trachomatis intraocular infection in the development of proliferative vitreoretinopathy (experimental study)].
    Boiko EV; Pozniak AL; Suetov AA; Mal'tsev DS; Nuralova IV
    Vestn Oftalmol; 2015; 131(1):50-57. PubMed ID: 25872387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.
    Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y
    Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR.
    Liou GI; Pakalnis VA; Matragoon S; Samuel S; Behzadian MA; Baker J; Khalil IE; Roon P; Caldwell RB; Hunt RC; Marcus DM
    Mol Vis; 2002 Dec; 8():494-501. PubMed ID: 12500176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.